Humana outperforms UnitedHealthcare with lower premiums and out-of-pocket costs. But UHC has higher quality ratings from the Centers for Medicare & Medicaid Services (CMS) and a large provider network ...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Leading health and well-being company Humana Inc. (NYSE: HUM) today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2025. This ...

Humana is a private insurer that offers Part D prescription drug coverage with some of its Medicare Advantage plans. The company also offers three stand-alone Part D options. Medicare Part D covers ...

Humana plans to achieve 4 stars in its Medicare Advantage star rating in 2028, according to information released during its Investor Conference on Monday. Humana told investors that it doesn't foresee ...

Tara covers the business of health care. Her stories focus on hospitals, doctors, and how their business practices affect patients — especially when private equity gets involved. She also writes about ...

More than 80% of Humana Medicare Advantage members will be in plans with stable benefits. Humana Medicare Advantage plans include preventive and diagnostic screenings for breast cancer, colon cancer ...

Humana, one of the largest U.S. sellers of Medicare Advantage insurance for older adults, will divest its stake in a provider of end-of-life services for $900 million.

Humana is a private insurance company that offers Medicare Advantage with Part D coverage and stand-alone Part D plans. Deductibles, monthly premiums, and drug copays depend on the specific plan.

June 10 (Reuters) - Humana said on Wednesday it has agreed to sell all or substantially all of its minority stake in Gentiva, a provider of hospice and palliative care services, in a deal valuing the ...

June 29 (Reuters) - Swedish care provider Ambea said on Monday it had made a recommended public offer for peer Humana, valuing the company at about 2.96 billion Swedish crowns ($304.13 million). • ...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (NYSE: HUM), a leading health and well-being company, today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2026.